Literature DB >> 33249916

Update on headache and brain tumors.

Antonio Palmieri1, Luca Valentinis1, Giorgio Zanchin2.   

Abstract

Headache is one of the leading symptoms often associated with brain tumours. Secondary headaches attributed to intracranial neoplasias have been included in subchapter 7.4 of the third edition of the International Classification of Headache Disorders (ICHD-3). According to ICHD-3, the headache may be attributed to a brain tumour if it has developed in close temporal relation with the development of the neoplasia, has significantly worsened in parallel with the worsening of the tumour, and/or has significantly improved following the successful treatment of the neoplasia. Brain tumour headache was traditionally thought to display some specific clinical characteristics, including worsening in the morning and/or when lying down, being aggravated by Valsalva-like manoeuvres and accompanied by nausea and/or vomiting; however, the studies performed after the advent of modern neurodiagnostic techniques have pointed out that the "classic" brain tumour headache is uncommon, particularly at the time of clinical presentation. Therefore, it becomes critical to seek some specific factors associated with the presence of an intracranial mass (the so-called "red flags") that can guide the physician to establish an accurate diagnosis.

Entities:  

Keywords:  International Classification of Headache Disorders; magnetic resonance imaging study; secondary headache disorders; tumour headache

Mesh:

Year:  2020        PMID: 33249916     DOI: 10.1177/0333102420974351

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  1 in total

1.  Prevalence and Risk Factors Associated with Tumors and Other Structural Anomalies in Brain MRI Performed to Rule out Secondary Headache: A Multicenter Observational Study.

Authors:  José Pablo Martínez Barbero; Antonio Jesús Láinez Ramos-Bossini; Mario Rivera-Izquierdo; Francisco Sendra-Portero; José Manuel Benítez-Sánchez; Jorge A Cervilla
Journal:  Int J Environ Res Public Health       Date:  2022-03-16       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.